DJIA 17,804.80 26.65 0.15%
NASDAQ 4,765.38 16.98 0.36%
S&P 500 2,070.65 9.42 0.46%
market minute promo

17.73 0.54 (3.14%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

INFI $17.73 3.14%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $17.15
Previous Close $17.19
Daily Range $16.85 - $17.78
52-Week Range $8.40 - $18.25
Market Cap $864.6M
P/E Ratio -78.14
Dividend (Yield) $0.00 (0.0%)
Volume 1,168,851
Average Daily Volume 769,363
Current FY EPS -$0.59

Sector

Healthcare

Industry

Drugs

Infinity Pharmaceuticals, Inc. (INFI) Description

The Company's mission is to discover, develop, and deliver to patients medicines for the treatment of cancer and related conditions. Website: http://www.infi.com/

News & Commentary

Dividend Aristocrats: Time to Buy AbbVie Inc Stock?

AbbVie is an innovative pharma company with an attractive yield and a strong outlook for top-line growth going forward. Here's why investors should dig into this top dividend stock.

Weakness Seen in Infinity Pharmaceuticals (INFI): Stock Falls 12.4% - Tale of the Tape

Monday's ETF Movers: OIH, XBI

Infinity Pharmaceuticals (INFI) Is Today's Strong On High Volume Stock

Infinity Pharmaceuticals (INFI) Is Strong On High Volume Today

Infinity Pharmaceuticals (INFI) Upgraded From Sell to Hold

Infinity Pharmaceuticals' (INFI) CEO Adelene Perkins on Q3 2014 Results - Earnings Call Transcript

Infinity Announces Clinical And Preclincal Data For Duvelisib To Be Presented at ASH 2014 Annual Mee

Infinity Announces Clinical And Preclincal Data For Duvelisib To Be Presented at ASH 2014 Annual Meeting

Will AVEO Pharmaceuticals (AVEO) Surprise this Earnings? - Analyst Blog

Will Synta Pharmaceuticals (SNTA) Post a Wider Q3 Loss? - Analyst Blog

3 Health Care Picks To Beat Earnings - Earnings ESP

See More INFI News...

INFI's Top Competitors

INFI $17.73 (3.14%)
Current stock: INFI
GILD $108.45 (2.76%)
Current stock: GILD
BIIB $360.67 (1.97%)
Current stock: BIIB
CELG $117.18 (0.60%)
Current stock: CELG